In one study, 42.23% of those on GLP-1 drugs reported nausea and 21.90% reported vomiting
Vasireddi, N., Hahamyan, H., Salata, M., Karns, M., Calcei, J., Voos, J., & Apostolakos, J
Other Ingredients: Capsules (Cellulose, water), rice powder, magnesium stearate, and silica
Locally available in Pakistan: There is no need to import unsafe or unconfirmed foreign products
Individuals with diabetes should be treated to meet a target systolic BP of 20 mg/mmol, on maximally tolerated, or maximally prescribed doses of RAASis, should be recommended an SGLT2i to delay progression of CKD and progression to dialysis, and to reduce likelihood of cardiovascular events [57,58,75,76] [Grade A, Level 1A]